◀ Back to FOS

FOS — SCT

Text-mined interactions from Literome

Goulet et al., Neuroscience 2003 : The peak blood levels of secretin that induce Fos protein expression in rat brain are similar to the peak blood levels observed during i.v. treatment with secretin in humans
Welch et al., Cell Mol Neurobiol 2003 : Secretin attenuated Fos immunoreactivity in the dorsal periaqueductal gray, intralaminar thalamus, medial parvicellular compartment of the hypothalamus, supraoptic nucleus of the hypothalamus, lateral amygdala, motor cortex, and the somatosensory and association areas of the parietal cortex
Yang et al., Neuroscience 2004 : Peripheral secretin induced Fos expression in the rat brain is largely vagal dependent ... Secretin ( 40 or 100 microg/kg, i.p., 90 min ) induced a dose related increase in the number of Fos positive neurons in the central nucleus of the amygdala (CeA), and a plateau Fos response in the area postrema ( AP ), nucleus tractus solitarii (NTS), locus coeruleus ( LC ), Barrington 's nucleus ( Bar ), external lateral subnucleus of parabrachial nucleus ( PBel ) and arcuate nucleus, and at 100 microg/kg, in the dorsal motor nucleus of the vagus ( DMV ) compared with i.p. injection of vehicle
Chu et al., PloS one 2013 : These treatments are found to be capable of blunting i.p. SCT induced Fos activation in pro-opiomelanocortin (POMC) neurons within the hypothalamic Arcuate Nucleus ( Arc )